Delivery Order SPE2DR25D3104-SPE2DR26FE9HT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,048.68 for Procainamide 1 gram/10 milliliter vials on January 2, 2026, with completion scheduled for January 5, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is a cardiac antiarrhythmic medication used to treat abnormal heart rhythms and is essential for...
- The Defense Logistics Agency awarded a delivery order valued at $4,532.88 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 26, 2025, with an ultimate completion date of November 28, 2025. This competitive, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,444.77 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procainamide 1,000 mg/10 mL vials (10 mL quantity). This firm fixed price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias and...
- The Defense Logistics Agency awarded a delivery order valued at $5,796.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/10 mL vials on November 14, 2025, with completion expected by November 17, 2025. Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias, and this competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $2,172.15. This award, issued on December 31, 2025, with an ultimate completion date of January 2, 2026, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $1,652.29. The contract, awarded on December 23, 2025, with an ultimate completion date of December 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,187.81 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This is a firm fixed-price contract with an ultimate completion date of January 12, 2026, and represents a competitively awarded, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp is a subsidiary of...
- The Defense Logistics Agency awarded a delivery order valued at $2,359.71 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 Gram/10 mL vials (10 mL quantity). This firm fixed-price delivery order, issued on January 16, 2026, carries an ultimate completion date of January 20, 2026, and was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,251.23 delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 9, 2026, for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order is scheduled for completion by January 12, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $5,005.35. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9HTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,764.42 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on January 16, 2026. This is a firm fixed-price contract with an ultimate completion date of January 20, 2026, and represents a non-competitive, non-set-aside award. The contractor will perform from its corporate office in Conshohocken, Pennsylvania. Procainamide is a cardiac antiarrhythmic medication used to treat irregular heart rhythms, making this a critical pharmaceutical supply for military medical facilities and healthcare systems supported by DLA. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award vehicle valued at up to $999,999,999.00 through December 2026. The IDC serves as the primary procurement mechanism for supplying comprehensive pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. As a major pharmaceutical distributor, Cencora/AmerisourceBergen fulfills critical medical procurement needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/15/26 |